Radiation oncology research and clinical trials to be featured at ASTRO's Annual Meeting

October 14, 2020

ARLINGTON, Va., October 14, 2020 -- The American Society for Radiation Oncology (ASTRO) announced today the studies that will be highlighted in the 2020 ASTRO Annual Meeting press program. The press program will feature studies on cancer treatment advances and discussions of topical issues including COVID-19 and racial representation in radiation therapy clinical trials. Researchers will present their findings in three news briefings to be held via live webcasts on October 26 and 27. Reporters can register for the briefings and embargoed access to news releases at http://www.astro.org/annualmeetingpress.

The news briefing schedule is as follows:

Monday, October 26, 12:00 - 1:00 p.m. ET


* "CCTG SC.24/TROG 17.06: A randomized phase II/III study comparing 24Gy in 2 stereotactic body radiotherapy (SBRT) fractions versus 20Gy in 5 conventional palliative radiotherapy (CRT) fractions for patients with painful spinal metastases," presented by Dr. Arjun Sahgal, University of Toronto (Abstract LBA-2)

* "Initial report of a randomized trial comparing conventional- vs conventional plus fluciclovine (18F) PET/CT imaging-guided post-prostatectomy radiotherapy for prostate cancer," presented by Dr. Ashesh Jani, Winship Cancer Institute of Emory University (Abstract LBA-1)

* "Phase III randomized trial of postoperative adjuvant conventional radiation (3DCRT) versus image guided intensity modulated radiotherapy (IG-IMRT) in cervical cancer (PARCER): Final analysis," presented by Dr. Supriya Chopra, Tata Memorial Centre (Abstract 2)

* "Stereotactic ablative fractionated radiotherapy versus radiosurgery for oligometastatic neoplasia to the lung: A randomised phase II trial," presented by Dr. Shankar Siva, Peter MacCallum Cancer Centre (Abstract 5)

* "Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4-15 brain metastases: A phase III randomized controlled trial," presented by Dr. Jing Li, The University of Texas MD Anderson Cancer Center (Abstract 41)

Tuesday, October 27, 12:00 - 12:30 p.m. ET


* "Characterization of underrepresented populations in modern era radiation therapy clinical trials," presented by Emily Hughes Bero, Medical College of Wisconsin (Abstract 204)

* "Geographic access to radiation therapy in the United States," presented by Dr. Sean Maroongroge, The University of Texas MD Anderson Cancer Center (Abstract 203)

* "Sexual health toxicity in cancer survivors: Is there a gender disparity in physician evaluation and intervention?" presented by Dr. James Taylor, Sidney Kimmel Cancer Center (Abstract 1042)

Tuesday, October 27, 2:00 - 3:00 p.m. ET - Special COVID-19 Session


* Update from the ASTRO COVID-19 Impact Survey

* Panel Discussion: "Low-Dose Radiation Therapy and COVID-19-related Pneumonia"

Originally planned as an on-site meeting in Miami, the 2020 ASTRO Annual Meeting was moved to a web-based platform due to safety concerns associated with the COVID-19 pandemic. The meeting, Global Oncology: Radiation Therapy in a Changing World, will feature more than 2,500 accepted abstracts including reports from the latest clinical trials; more than 120 expert panels on topics including global oncology, health disparities and the novel coronavirus; and an immersive attendee experience in a virtual convention center.

Press registration and other media resources are available in the online press kit, and ASTRO's media relations team is available at press@astro.org or 703-286-1600 to answer questions related to the press program. General information about the meeting is available at the ASTRO Annual Meeting webpage and session/presentation details are available in the Online Conference Planner.
-end-
ABOUT ASTRO

The American Society for Radiation Oncology (ASTRO) is the world's largest radiation oncology society, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. The Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes three medical journals, International Journal of Radiation Oncology * Biology * Physics, Practical Radiation Oncology and Advances in Radiation Oncology; developed and maintains an extensive patient website, RT Answers; and created the nonprofit foundation Radiation Oncology Institute. To learn more about ASTRO, visit http://www.astro.org.

American Society for Radiation Oncology

Related Radiation Therapy Articles from Brightsurf:

Pulmonary artery thrombosis a complication of radiation therapy
According to ARRS' American Journal of Roentgenology, the imaging findings of in situ pulmonary artery thrombosis (PAT) associated with radiation therapy (RT) are different from those of acute pulmonary emboli and do not appear to embolize.

New approach for calculating radiation dosimetry allows for individualized therapy
Researchers have developed a simplified process that could enhance personalization of cancer therapy based on a single nuclear medicine scan.

Developing microbeam radiation therapy (MRT) for inoperable cancer
An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by University of Saskatchewan (USask) researchers at the Canadian Light Source (CLS).

Travel considerations specified for 177Lu-DOTATATE radiation therapy patients
Researchers and patient advocates have addressed the challenges related to traveling after receiving 177Lu-DOTATATE radiation therapy in a study published in the April issue of The Journal of Nuclear Medicine.

A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.

AI can jump-start radiation therapy for cancer patients
Artificial intelligence can help cancer patients start their radiation therapy sooner -- and thereby decrease the odds of the cancer spreading -- by instantly translating complex clinical data into an optimal plan of attack.

Towards safer, more effective cancer radiation therapy using X-rays and nanoparticles
X-rays could be tuned to deliver a more effective punch that destroys cancer cells and not harm the body.

Radiation therapy effective against deadly heart rhythm
A single high dose of radiation aimed at the heart significantly reduces episodes of a potentially deadly rapid heart rhythm, according to results of a phase one/two study at Washington University School of Medicine in St.

New mathematical model can improve radiation therapy of brain tumours
Researchers have developed a new model to optimize radiation therapy and significantly increase the number of tumor cells killed during treatment.

Using artificial intelligence to deliver personalized radiation therapy
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to personalize the dose of radiation therapy used to treat cancer patients.

Read More: Radiation Therapy News and Radiation Therapy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.